UK markets closed

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
31.47+0.94 (+3.08%)
At close: 04:00PM EST
32.00 +0.53 (+1.68%)
After hours: 06:16PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1471616
Avg. Estimate-0.79-0.74-2.58-2.99
Low estimate-0.98-0.78-2.83-3.76
High estimate-0.41-0.68-2.15-2.34
Year ago EPS-0.62-0.53-2.39-2.58
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1271515
Avg. Estimate14.21M18.79M110.37M93.32M
Low estimate3M5M100M33.4M
High estimate53M35M151M150M
Year ago sales12.51M42.14M48.66M110.37M
Sales growth (year/est)13.60%-55.40%126.80%-15.40%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.41-0.51-0.55-0.81
Actual EPS-0.62-0.53-0.48-0.84
Difference-0.21-0.020.07-0.03
Surprise %-51.20%-3.90%12.70%-3.70%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.79-0.74-2.58-2.99
7 days ago-0.79-0.74-2.58-2.99
30 days ago-0.82-0.74-2.6-3
60 days ago-0.8-0.73-2.62-3
90 days ago-0.83-0.75-2.6-2.75
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesDNLIIndustrySector(s)S&P 500
Current qtr.-27.40%N/AN/AN/A
Next qtr.-39.60%N/AN/AN/A
Current year-7.90%N/AN/AN/A
Next year-15.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A